Jörg P Halter

23PUBLICATIONS

64CO-AUTHORS

Implementation science and evaluationPharmacogenomicsImmunology not elsewhere classifiedHaematological tumoursGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|Jul 01, 2026

Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

|Jun 24, 2026

Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

|May 26, 2026

Low-positive CMV IgG serostatus before allogeneic hematopoietic cell transplantation is not associated with increased CMV reactivation risk.

|Mar 04, 2026

Frequent NPM1 mutation, monoblastic/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study.

Alex Jenei, Béla Kajtár, Tamás László

|Jan 14, 2025

Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis.

Silke Heidenreich, Katharina Egger-Heidrich, Jörg P Halter

|Aug 13, 2024

Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation.

Marie Janscak, Anne Stelmes, Jana van den Berg

Pageof 4

Frequent Collaborators

Jakob R Passweg

Michael Medinger

Yves Chalandon

Claire Seydoux

Christian Arranto

Andreas Buser

Tayfun Güngör

Chakradhara Rao Satyanarayana Uppugunduri

2 joint publications

Tiago Nava

2 joint publications

Nathan Cantoni

Frequent Collaborators

Jakob R Passweg

Michael Medinger

Yves Chalandon

Claire Seydoux